REPROGEN INC has a total of 28 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are AGROBIOGEN GMBH BIOTECHNOLOGIE, INGENY BV and MOUNT SINAI MEDICAL CENTER.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Canada | 4 | |
#5 | United States | 4 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Medical preparations | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Yamamoto Karen K | 23 |
#2 | French Cynthia K | 18 |
#3 | Schneider Patrick A | 10 |
#4 | Schneider Patrick | 6 |
#5 | Strauss Jerome J | 5 |
#6 | Boyd Jeffrey | 5 |
#7 | Li Zhen | 5 |
#8 | Neilson Lorna | 4 |
#9 | Van Deerlin Peter | 4 |
#10 | Neilson Lorna I | 4 |
Publication | Filing date | Title |
---|---|---|
EP1400247A1 | Treatment of endometriosis with antileukoprotease | |
US6544740B1 | Treatment of endometriosis with antileukoprotease | |
CA2299436A1 | Use of prothymosin in the diagnosis and treatment of endometriosis | |
NZ508690A | Use of cathepsin S in the diagnosis and treatment of endometriosis | |
US6753138B1 | Use of prothymosin in the diagnosis and treatment of endometriosis | |
US6429353B1 | Endometriosis mouse model | |
AU6545898A | Method for identifying hormonally modulated genes | |
AU6664798A | Nucleic acids encoding sperm antigens and reprosa-i polypeptides |